US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 475 actively recruiting studies with Ohio sites out of 475 registered in total. The busiest research areas in Ohio are Ovarian Cancer, Solid Tumor, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, The Cleveland Clinic, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (96), Phase 2 (140), Phase 3 (106), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
475
Recruiting Now
475
← Back to US Map
Top Conditions in Ohio
Ovarian Cancer (9)Solid Tumor (8)Advanced Solid Tumor (8)Heart Failure (7)Colorectal Cancer (7)Prostate Cancer (7)Schizophrenia (7)Acute Myeloid Leukemia (6)Advanced Solid Tumors (6)Chronic Lymphocytic Leukemia (6)Multiple Myeloma (5)Metastatic Castration-resistant Prostate Cancer (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 475 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 475. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Solid Tumor, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT07562997 N/A
Recruiting
Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm ...
Condition
Very Preterm and Extremely Preterm Birth
Enrollment
150 pts
Location
United States
Sponsor
University of Washington
View Trial →
NCT06174103 N/A
Recruiting
BiVACOR® Total Artificial Heart Early Feasibility Study
Condition
Heart Failure
Enrollment
20 pts
Location
United States
Sponsor
BiVACOR Inc.
View Trial →
NCT07190196 Phase 3
Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adul...
Condition
Immunoglobulin G4 Related Disease
Enrollment
124 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
View Trial →
NCT07321353 N/A
Recruiting
Survivors Journey+
Condition
Pediatric Brain Tumor
Enrollment
72 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05796375 Phase 2
Recruiting
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder...
Condition
Non-muscle-invasive Bladder Cancer
Enrollment
240 pts
Location
United States
Sponsor
White River Junction Veterans
View Trial →
NCT07221357 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated, Unresectable, or Metastatic Colorectal Cancer
Enrollment
990 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rea...
Condition
Acute Myeloid Leukemia
Enrollment
447 pts
Location
United States, Australia, Canada
Sponsor
Syndax Pharmaceuticals
View Trial →
NCT05552222 Phase 3
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR)...
Condition
Multiple Myeloma
Enrollment
1,590 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
View Trial →
NCT07231419 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With ...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
734 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07628647 N/A
Recruiting
Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Perso...
Condition
Brain Cancer
Enrollment
64 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Condition
Cancer
Enrollment
619 pts
Location
United States, Australia
Sponsor
Parabilis Medicines, Inc.
View Trial →
NCT05254171 Phase 2, Phase 3
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Ca...
Condition
Pancreatic Cancer Metastatic
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Panbela Therapeutics, Inc.
View Trial →
NCT02744677 N/A
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients...
Condition
Complex Congenital Heart Defect
Enrollment
108 pts
Location
United States
Sponsor
Edwards Lifesciences
View Trial →
NCT04858412 N/A
Recruiting
Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Live...
Condition
Alcoholic Liver Disease
Enrollment
48 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT04047628 Phase 3
Recruiting
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for ...
Condition
Relapsing Multiple Sclerosis
Enrollment
156 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT06657222 Phase 1, Phase 2
Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
250 pts
Location
United States, Canada, France
Sponsor
Gilead Sciences
View Trial →
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Argentina, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07124000 N/A
Recruiting
DESTINY-PANTUMOUR04
Condition
Adenocarcinoma (NOS)
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT07105111 Phase 4
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With ...
Condition
Schizophrenia
Enrollment
100 pts
Location
United States
Sponsor
Neurocrine Biosciences
View Trial →
NCT06127199 N/A
Recruiting
Contraceptive Efficacy Study of Ovaprene
Condition
Contraception
Enrollment
656 pts
Location
United States
Sponsor
Daré Bioscience, Inc.
View Trial →
NCT06007872 N/A
Recruiting
Intracardiac Echocardiography Guided Watchman Device Implant
Condition
Atrial Fibrillation
Enrollment
100 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT04049539 Phase 1, Phase 2
Recruiting
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persis...
Condition
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells
Enrollment
28 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT05135975 Phase 2
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurre...
Condition
Neuroblastoma
Enrollment
86 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
Page 1 of 19 — 475 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology